Here is updated Fellowship info. please remember to send CV and CREOG scores in addition to ERAS application

Summary Description of Fellowship Program

General Objectives:

1. To educate obstetrician-gynecologists in the comprehensive management of women with cancer of the reproductive organs via exposure to a broad base of patient diagnoses, treatments and demographics. This is achieved through exposure to four board certified gynecologic oncologists all trained at different institutions, and serving a different mix of patient diagnoses and patient demographics.
2. To foster the development and maturation of future academic physician-scientists and leaders within the field of gynecologic oncology via exposure to a selection of state-of the art collaborative NIH-funded laboratories (within the Basic Reproductive Sciences Division of the Department of Obstetrics and Gynecology) and via post-fellowship application to approved on-site professional development programs such as The Women’s Reproductive Health Research (WRHR) program, K-12 (Paul Calabrese) Clinical Oncology Scholars Program, K30 Masters in Clinical Sciences Program (through the Colorado Clinical Translational Sciences Institute), or Building Interdisciplinary Research Careers in Women’s Health (BIRCWH) program.

Specific Objectives (ACGME Core Competencies Addressed*):

1. Be able to perform a comprehensive gynecologic and related cancer directed history and physical, select and perform diagnostic techniques to establish extent of disease, and plan and execute an ethical and logical treatment plan, including the use of chemotherapy, surgery, radiation therapy (via a dedicated Radiation Oncology Rotation) and targeted biologic therapies (via enrolling patients in Gynecologic Oncology Group and Phase I trials). Be able to manage complications resulting from these therapies (I,II,III).
2. Identify pathologic features of malignant gynecologic and related cancer conditions and differentiate these from benign entities (II).
3. Be knowledgeable in pre- and post operative management of patients with gynecologic and related cancers, including identification and management of complications, pain management, fluid and electrolyte management, nutrition, blood and blood component therapy, artificial ventilation, and organ failure. This objective is also enabled by a dedicated SICU rotation. (I, II, III).
4. Master the current knowledge regarding carcinogenesis, hereditary cancer syndromes, oncogenes and tumor suppressor genes and tumor immunology (II).
5. Design, implement and present grant proposals, experiments, and manuscripts using sound and logical epidemiologic and statistical principles. Understand the principles of medical ethics and the purposes of review boards in research (III, IV).
6. Follow treatment outcomes over time, modify treatment approaches to optimize outcomes, analyze systems errors that impede successful patient care and plan remedial strategies (III, VI).
7. Recognize patient and family dynamics in cancer diagnosis and treatment, become comfortable presenting end of life care options and assist the patient and family in transitioning from active treatment to palliative care (IV, V).

*The University of Colorado Denver School of Medicine ACGME Core Competency Areas:

I. Patient Care
II. Medical Knowledge
III. Practice-Based Learning and Improvement
IV. Interpersonal and Communication Skills
V. Professionalism
VI. System Based Practice

1. Education Program

a. Organization of in- and out-patient teaching (by institution/facility)

Year one of the fellowship will be devoted to the study of basic science and translational research in gynecologic oncology. Years two and three will be devoted to building on the foundations of the first year and acquiring increasing patient care, medical knowledge, practice-based learning and improvement, interpersonal and communication skills, and attendant responsibility.

A structured teaching format throughout the fellowship at all sites (University of Colorado Hospital(UCH), Denver Health Medical Center, a public-tax supported county hospital (DHMC), and Swedish Medical Center, a private hospital (SMC)) will be used to attain these goals. UCH and DHMC have been staffed by the full time faculty of the University of Colorado Denver Obstetrics and Gynecology Department and Residency program for greater than 30 years. SMC has been staffed by the same program faculty gynecologic oncologist for greater than 15 years.

DHMC is an integral part of the graduate medical education program of the University of Colorado Denver. DHMC provides care to the uninsured population of Denver County and shares all faculty and residents with UCH. Furthermore, DHMC provides diversity to the experience of the fellow and highlights the issues of patients covered under public funding of healthcare.

SMC was added in 2010 as a training site to enhance the demographic diversity of Denver area patients available for fellowship training (by including a private practice population from a different catchment area and referral source) and to expand the experience of the fellow in radical and minimally invasive surgery (as requested by the reviewers in the 2010 ABOG annual review). The experienced program faculty member at SMC is also integrated into the UCH/DHMC academic program by participating in joint tumor conferences and teaching conferences and is affiliated with UCH/DHMC for enrollment of patients on clinical trials and through the Gynecologic Oncology Group.

1. Inpatient Teaching (UCH):

The second and third year fellows (clinical fellows) will have duties every day at UCH with the exception of the second year fellow who will go to DHMC on the first and third Tuesdays (rounds and surgery) and on Wednesday afternoons (rounds and gynecologic oncology clinic) and the third year fellow who will go to SMC every Tuesday (rounds and surgery). The teaching inpatient rounds schedule at UCH will be as follows:

Weekday Mornings (6 am - 8:30 am)

Fellows will round and teach the practical aspects of inpatient care to the residents and medical students. The junior fellow will lead rounds and the senior fellow will supervise (or either fellow will round when both fellows are not present). Attending staff (one assigned every day to formally round on all patients) will round with the team and oversee the clinical decision making and provide additional teaching. Mondays and Fridays are dedicated morning lecture days for the fellows and a formal lecture may be given to the fellows during this time by program faculty (8-8:30 am) or they may be excused to attend a formal lecture (7-8:30 am). Progressive responsibility will be provided by allowing the junior fellow to receive clinical information first and formulate a plan, the senior fellow to process presented information and modify the plan and both to discuss the outcome prior to presenting it to the attending staff. During the day, faculty will be immediately available on site for supervision.

Weekday afternoons (4:30 pm – 6 pm):

Attending staff will review the events of the day with the fellows and make plans for sign-out.

2. Outpatient Teaching (UCH):

In the outpatient setting, the fellows will see patients prior to the attending staff and will be given the opportunity to integrate clinical data and formulate a management plan. The fellows will lead a didactic session on Wednesday mornings prior to clinic. Journal club occurs on the last Wednesday of the month. Didactic lectures are built into the inpatient schedule (see above) and additional focused formal teaching sessions are planned for Tuesdays and Fridays at 12:30 to provide additional time for discussion of specific topics relevant to gynecologic oncology. The fellows, residents and students will participate in this educational conference.

Thursdays (7:00 am to 8:00 am):

All pathology specimens will be reviewed with pathology attending staff at this weekly pathology teaching conference and multidisciplinary management decisions will be made. (Gynecologic Oncology Pathology, Radiology and Tumor Treatment Planning Conference). Faculty, fellows, residents and students from Gynecologic Oncology, Pathology, Diagnostic Radiology and Radiation Oncology will participate. The senior fellow will direct the conference and senior and junior fellows will formulate the management plan followed by a general discussion lead by attending staff. Attending staff from DHMC and SMC attend this conference and present preoperative , postoperative, and consult cases for treatment planning.

3. Inpatient teaching (DHMC):

1rst and 3rd Tuesdays (7 am to 7:30 am), Wednesdays (1-1:30 pm).

Attending staff will conduct rounds with residents and medical students and they will be available on-site for supervision. The junior (second year) fellow will lead these rounds. Attending staff will review all clinical decision making.

4. Outpatient Teaching (DHMC):

Wednesdays (1 pm – 5 pm)

The weekly DHMC clinic is led by the second year fellow. Residents and medical students interview and examine the patients and present them to the second year fellow. The fellow formulates a management plan, including decisions for surgery or chemotherapy or radiation therapy, and presents those plans to the faculty on site. Treatment plans are reviewed by the entire program faculty as these patients are presented at the combined Thursday morning tumor planning conference at UCH.

5. Inpatient teaching (SMC):

Tuesdays (7:30 am-5 pm),

Attending conduct rounds with the fellow prior to surgery, and supervise and teach the fellow in the operating room. Attending staff review all clinical decision making.


6. Outpatient Teaching (SMC):

Treatment plans are reviewed by the entire program faculty at the combined Thursday morning tumor planning conference at UCH.



b. The residency program in Ob/Gyn. Indicate the number of residents in obstetrics and gynecology at your institution and the number of fellows currently in other subspecialty fellowship programs

The obstetrics and gynecology residency at the University of Colorado Denver is approved for 9 residents/year, for a total of 36. The program had its last RRC site visit in 2/07 and received full accreditation. The next site visit will be in 2011. Throughout the year, four residents (first, second, third and fourth year) as assigned to the gynecologic oncology service at UCH and a third year resident is assigned to the gynecologic oncology service at DHMC. There are no residents at SMC. The Department of Obstetrics and Gynecology also supports an MFM fellowship (2/year, 3 years), and REI fellowship (1/year, 3 years) and a family planning fellowship (1/year, 3 years). A urogynecology/female pelvic reconstructive surgery fellowship application is planned for 2011.


c. Relationship with the departments of Surgery, Urology, Medical Oncology and Radiotherapy.


The division of gynecologic oncology has worked closely in the last 15 years with the following departments in the following ways:


1. Surgical Oncology (Drs. Nathan Pearlman, Martin McCarter, and Czaba Gajdos)
-Consultation on patients with suspected ovarian cancer who are found to have G.I. tract malignancies
-extensive upper abdominal and hepatic resections
-trans-diaphragmatic resection of pleural based metastases
-diaphragmatic and peritoneal stripping
2. Urologic Oncology (Drs. Shandra Wilson and Paul Maroni)
-Continent conduits attached to preserved bladder neck/urethra
-Continent conduits accessed via the umbilicus

3. Medical Oncology (Drs. Gail Eckhart and Jennifer Diamond)
-access to phase 1 trials for gynecologic oncology patients
-formal cooperation as faculty for a Gynecologic Oncology Group phase I site
4. Radiotherapy (Dr. Tracey Schefter)
-radiotherapy for gynecologic malignancies
-formal one month rotation for the 3rd year gynecologic oncology fellow

The faculty of the Division of Gynecologic Oncology are themselves experienced in colorectal surgery, surgery on the urinary tract and reconstruction after radical surgery. We however recognize and value the expertise of specialists within these fields that offer cutting edge solutions to the management of difficult problems and incorporate these into our patient care. Chemotherapy is done entirely within our division. Dr. Tracey Schefter, who performs radiotherapy for gynecologic cancer is listed as program faculty and the senior fellow spends a one month rotation on her service. Additionally, Dr. Schefter attends the weekly Gynecologic Oncology pathology and treatment planning conference.

Additionally, the Division of Gynecologic Oncology is assisting the Departments of Surgery, Urology and Pharmacology (Kian Behbakht, M.D. with Martin McCarter, M.D., Dan Theodorescu, M.D., Ph.D., Director of the University of Colorado Cancer Center, Andrew Thorburn, Ph.D., Chair of Pharmacology) in writing an Educational T32 Grant to further the basic/translational science education of cancer surgeons at the University of Colorado Denver.


d. Progressive responsibility of the fellows as they advance yearly in the program

Progressive, mentored, and supervised responsibility is the hallmark of this fellowship. Increasing responsibility is provided to the fellows in the office setting and in the operating room as their clinical and technical skills mature throughout the fellowship. In the operating room the junior fellow will be initially expected to lead operations such as a simple hysterectomy for benign conditions with the faculty as first assistant. With experience the fellow will be expected to lead an upper level resident through the operation with the attending functioning as a 2nd assistant and providing direct supervision. As the fellow becomes more experienced in performing more complicated operations, they will increasingly assume the lead surgeon role with the faculty always present as first or second assistant. For example, the fellow will be expected to perform a radical hysterectomy with pelvic and para-aortic lymphadenectomy, an ovarian cancer debulking or a radical vulvectomy with inguino-femoral lymph node dissection by the completion of their fellowship. Fellows will be supervised by an attending gynecologic oncologist during fellowship related activities in all settings.

e. Educational experiences for the fellows in clinical pharmacology, pathology and radiation oncology

Fellows will complete the computerized chemotherapy order entry system training. They will augment this structured knowledge with dedicated lectures in writing chemotherapy and managing complications and with practice by entering and reviewing chemotherapy orders in their next two/clinical years. They will write all inpatient chemotherapy orders and review the outpatient chemotherapy orders for approval (done electronically). Further teaching will be provided when orders are reviewed by the patient’s attending gynecologic oncologist.

Fellows will participate in weekly pathology/treatment planning conferences. These will be attended by pathologists, radiologists, and radiation oncologists. Miriam Post, M.D., Assistant Professor of Pathology with special expertise in Gynecologic Pathology, her residents, and fellows will be present at this conference and will provide in depth teaching. A weekly gynecologic pathology didactic is planned to start in 2011. Additionally, fellows will
sharpen their radiation oncology skills during their senior year radiation oncology formal rotation (supervised by Tracey Schefter, M.D., Radiation Oncologist with fellowship training in Gynecologic Radiation Oncology).



2. Responsibilities and Activities of Fellows

a. Teaching of residents and students

1. The senior fellow will give a formal lecture (Fellow Didactic) on a weekly basis to the residents and students on service (Wednesdays 8:00-9:00).
2. The fellows will be expected to provide “bedside” teaching for the residents and students on AM and PM rounds and in the operating room on a daily basis.
3. Fellows will be formally evaluated by both residents and medical students and their progress as educators will be reviewed with them by the fellowship director quarterly.
4. Fellows will be given the rank of “Instructor” in the School of Medicine.

b. Obstetrics and c. Benign gynecology

The laboratory year (year one) fellow will cover gynecology services at the Veteran’s Administration Hospital not to exceed one half day/week. This will constitute outpatient clinic and/or surgery and will be preferentially biased toward management of pre-invasive disease. This activity is limited to the first year of the fellowship. The only responsibility of the second and third year fellows to the benign gynecology service and obstetrics service is to respond to calls requesting consultation from the gynecologic oncology service. On all surgical consults, the fellow will be supervised by a gynecologic oncology attending. On inpatient consults, the gynecologic oncology attending will see the patient with the fellow within 24 hours. Fellows will attend the Departmental Morbidity and Mortality Conferences (Mondays 4 pm) where their input in the management of benign gynecology and obstetrics patients in their capacity as active candidates or board certified obstetrician/gynecologists will be encouraged.

d. Lectures and presentations

1. Within the first 3 months of starting, the first year (laboratory) fellow will present their research at the Basic Reproductive Sciences Symposium (4 pm Tuesdays) and form a mentoring committee which will monitor their progress via quarterly presentations by the fellow. Within one month of finishing the research year, the fellow will present final results, anticipated national presentation and manuscript dates and plans to continue research during fellowship. The fellow will give a formal thesis presentation and present a written thesis report prior to graduation from the fellowship.

2. The junior (2nd year) and senior (3rd year) fellows will give a formal lecture (Fellow Didactic) on a weekly basis to the residents and students on service (Wednesdays 8:00-9:00).

3. The fellows are encouraged and supported through travel funds in their respective grants and through an unrestricted educational fund set up through the University of Colorado Foundation to attend and present at regional and national meetings. These include but are not limited to SGO, WAGO, AACR, American Society of Clinical Oncology (ASCO), American College of OB/GYN (ACOG) and Society of Gynecologic Investigation (SGI).


e. Call-State if home/pager and in-house call is included in the 80-hour work week.

Call is entirely home/pager unless the critical nature of a patient’s care requires the fellow to return in-house. All in-house hours will be included in the 80 hour work week and ACGME guidelines for the 80 hour work week will be followed. If a fellow is called in after-hours, in-house hours begin when the fellow arrives at the medical center and conclude when the fellow leaves the medical center. Fellows will keep a log of all in-house after-hours calls. A detailed description can be found in the 2010-2011 GME manual (pages 42-43) from the University of Colorado Denver. This is also available on-line in searchable pdf form at: http://ucdenver.edu/academics/colleges/medicalschool/education/graduatemedicaleducation/ResidentsFellows/Pages/Index.aspx. The fellows are provided a copy of this and can also view updated on-line copies.

f. Moonlighting – State is moonlighting (internal and external) is included in the 80-hour work week?

External moonlighting is not mandated in this fellowship. Internal moonlighting at the VA accounts for 10% of work hours only during the first (laboratory) year and is part of the work hours. External moonlighting is not recommended and must follow the GME guidelines.

g. Tracking and documentation of the fellows’ time

Fellows are queried about their compliance with the 80 hour work week at their quarterly fellow review with the program director and keep a log of ALL after-hours in house hours. The fellow work hours are reviewed quarterly by the program director. Fellows are provided with the ACGME guidelines for the 80 hour work week and are required to complete an on-line fatigue module.

h. Policy regarding leave for fellows

Fellows as provided with the University of Colorado Denver GME leave policies which include provisions for Family and Medical Leave of Absence, Educational Leave, Military Leave, Sick Leave and Vacation. Details are available in the GME manual pages 53-55 with the exception that for this fellowship program, Educational leave is increased from 7 calendar days to 14 calendar days and Vacation leave is decreased from 21 calendar days to 14 calendar days.

3. Research

a. The facilities within the division or department for clinical research/laboratory research (sq. ft., location, and equipment available for fellow research training. Please include the library facilities, any literature search programs, any clinical databases, and access to medical records that are available for fellows for clinical research.

Laboratory facilities (in the department of Obstetrics and Gynecology) available to the fellow are located on the 5th floor of the state-of-the-art Research Complex 1 Building at the Anschutz Medical Campus of the University of Colorado Denver. The gynecologic oncology laboratories are housed within the Basic Reproductive Sciences (BRS) Division of the Department of Obstetrics and Gynecology. The BRS division (Director: Jim McManaman, Ph.D.) was specifically instituted in 1999 to stimulate a collaborative relationship between basic and clinical faculty leading to combined projects culminating in increased grant funding, publications and progress of medical science. The BRS Division occupies over 5000 square feet and houses 5 full time Ph.D.s, two MD/PhDs, a biostatistician and an MD with significant research support. The Gynecologic Oncology Laboratories are under the direction of Dr. Kian Behbakht and Dr. Monique Spillman and include 1500 square feet of independent space and an additional 2500 square feet in collaboration with Dr. Heide Ford. The lab includes a cell culture hood, 2 incubators, biohazard and fume hoods, 4 degree refrigerator and -20 degree and -80 degree freezers, 2 liquid nitrogen storage tanks, multiple gel electrophoresis devices, 2 power supplies, an ABI 9700 thermocycler, a Molecular Devices kinetic plate reader, 2 microcentrifuges, shaking water bath, tissue homogenizer, 2 rocking platforms and pH meter. Four laboratory desks and two adjacent 100 square foot offices currently contain four Dell computers and an NEC laptop dedicated to research as well as software with Microscoft Office, Adobe Photoshop, Adobe Acrobat, SPSS version 11.0. 2, one inkjet and one color laser printer.

Shared resources within the BRS Section include a digital confocal microscope and additional cell culture facilities. The BRS division also shares two Beckman centrifuges, a Speed Vac, BioRad gel dryer, Beckman UV/Vis spectrophotometer, a Nikon inverted microscope with fluorescent and digital capabilities, a Zeiss Axioplan light microscope, a BioRad gel documentation device, laboratory grade dishwasher, ice machine and autoclave. Equipment for bacterial cultures is available in the shared equipment corridor. The laboratories are hence fully equipped for biochemistry and molecular biology.

The Gynecologic Oncology Laboratory uses an on-site fully accredited (AALAC) animal facility including SCID and athymic nude mouse housing, equipped with modern cage washing and sterilization equipment, fully duplicated HVAC with HEPA filtered, non-reutilized intake and exhaust air, and separate procedure rooms. An on-site animal imaging facility has capability for animal IVIS, PET, CT and MRI scanning.

The University of Colorado Comprehensive Cancer Center Core facilities, located in the same building as the Gynecologic Oncology Laboratory, include a real-time PCR core, antibody production core, flow cytometry core, microarray core and laser capture microdissection core.

The Denison Memorial Library was established in 1924 to commemorate Charles Denison, a Colorado Physician and Professor of Chest Diseases. The dedication address was given by Dr. Florence Sabin. The new library on the Anschutz Medical Campus opened in 2007 and is a state-of-the-art facility providing print journals and 24/7 on-line access to pdf files and database searches (including PubMed, Ovid, micromedex and Harrison’s ). On-line library classes are provided. This extensive outreach allows rapid database searches and retrieval of on-line pdf manuscripts at no cost.


b. The percentage of fellowship time reserved for research, how this is distributed, and any other non-research activities that the fellows have during that time, including night call and moonlighting.

The entire first year of the fellowship is reserved for research with the exception of 10% time spent at the VA. There is no night call during the research year. Continuation of research into the second year and beyond, especially with projects that have a translational/patient oriented or outcomes component is encouraged.

c. How provisions are made for identifying a research mentor and thesis project for the fellow.

Research opportunities and mentorship will be available from all members of the Division of Gynecologic Oncology and the Division of Basic Reproductive Sciences in the Department of Obstetrics and Gynecology.

The Division of Basic Reproductive Sciences (BRS) was founded in 1999 with the mission of integrating scientific discovery into clinical medicine. Led by Jim McManaman, Ph.D., Professor of Obstetrics and Gynecology, and Physiology & Biophysics, the BRS section currently provides the educational environment for 4 Women’s Reproductive Health Research (WRHR) scholars and a graduate program culminating in a Ph.D. in Reproductive Sciences (with 5 current graduate students). Five full time Ph.D.’s and 2 members of the division of gynecologic oncology (Kian Behbakht, M.D. and Monique Spillman, M.D., Ph.D.) constitute core BRS faculty and oversee greater than 6 million dollars in research funding. All BRS faculty are experienced mentors with a solid track record of teaching graduate students, medical students, post-doctoral students, residents, fellows (Maternal Fetal Medicine , Pediatric Oncology, Medical Oncology) and junior faculty.

Incoming fellows will be queried regarding their research interests by the fellowship director and will be presented with a list of possible projects and mentors within and outside the department of OB/GYN. Within 3 months of beginning the fellowship, the fellow will present a seminar at the Basic Reproductive Sciences Symposium presenting their hypothesis and reviewing the literature. A formal mentoring committee will then be formed and meet within a month of this presentation. Possible projects include:

Principal Investigator: Kian Behbakht, M.D.
Projects: “Homeobox gene Six1 over-expression and TRAIL resistance in ovarian cancers”.
“Six1 expression in circulating tumor cells as a biomarker for ovarian cancer.”
Major Funding: Department of Defense Idea Award in Ovarian Cancer
NIH R01

Principal Investigator: Monique Spillman, M.D., Ph.D.
Projects: “Steroid hormone regulation of ovarian cancer in xenograft models”
Major Funding: The Gynecologic Cancer Foundation/Susan G. Komen Foundation

Principal Investigator: Andrew Bradford, Ph.D.
Projects: “Ets factors in endometrial cancer”.
Major Funding: NIH R01

Principal Investigator: Heide Ford, Ph.D.
Projects: “Six1 and metastases in breast and ovarian cancers”
Major Funding: NIH R01

Principal Investigator: Twila Jackson, Ph.D.
Projects: “Non genomic actions of estrogen in endometrial cancer”
Major Funding: NIH R01

Additionally, members of the Basic Reproductive Sciences Division collaborate extensively with other scientists within the University and at surrounding university campuses. Examples of these include:

Drs. Kian Behbakht and Heide Ford with Drs Andrew Thorburn and Christine Wu (both from Department of Pharmacology) on Six1 and TRAIL sensitivity in ovarian cancer.

Drs. Monique Spillman and Kathryn Horowitz (Department of Medical Endocrinology) on “Differences in steroid hormone regulated transcription in breast and ovarian cancers.”

Dr. Heide Ford with Dr. Rui Zhao (Department of Biochemistry and Molecular Genetics) on “Structural and functional analysis of the Six1 transcriptional complex as an anti-cancer target”

Drs. Andrew Bradford and Twila Jackson with Dr. Jennifer Richer (Pathology) on genetic analysis of leiomyomas and leiomyosarcomas and Protein Kinase expression in endometrial cancers.


d. The curriculum of research development, to include mentorship and personnel support, to provide the fellows training/experiences in:

1) IRB training.

The Colorado Multiple Institution IRB (COMIRB) offers courses (COMIRB 101 ) for fellows not experienced in IRB training. These are mandatory for physicians submitting IRB protocols. Drs Spillman and Behbakht are also experienced in completing IRB applications and provide their mentorship as needed.

2) Grant writing
Free Courses are offered through the Colorado Clinical Translational Science Institutes (CCTSI).

3) Statistical Analysis/4) Study Design
A monthly lecture series provided for free by the CCTSI covers all aspects of statistical analysis and study design and is free.

4) Manuscript preparation.

The draft copy of the manuscript is written by the fellow. The mentoring committee and co-authors review the manuscript and suggest appropriate journals. Progress of the fellow towards the goal of a thesis and published manuscript will be evaluated with weekly lab meetings in the first (laboratory) year and quarterly review of progress during the second and third (clinical) years. Quarterly review of progress will be overseen by a 4 member thesis committee consisting of experts in the area of the Fellow’s thesis in a manner similar to that for the on-site WRHR scholarship. Fellows will be encouraged to continue scholarly activities such as application to the WRHR scholarship, the BIRCWH scholarship, or the K12 mentored clinical oncology scholars program (via the University of Colorado Comprehensive Cancer Center and CCTSI) upon completion of their gynecologic oncology fellowship.

5) Thesis presentation/defense.

The fellow will present the results of their first year research (within one month of completing the year) at the Basic Reproductive Sciences Symposium and to their mentoring committee. Fellows will write a formal thesis document and present a thesis defense prior to graduation.

Application to our Gyn Onc program

We are accepting applications through ERAS. Please also send a CV and CREOG scores to either myself kian.behbakht@ucdenver.edu or Nancy McKee at nancy.mckee@ucdenver.edu. Our application deadline is the ERAS post office closure. Good Luck. KB